Incarcerated Umbilical Hernia Treated With Adhesive Strapping in a Three-Month-Old Infant

Masazumi Miyahara1, Kyoko Osaki1

  • 1Department of Pediatrics, Okanami General Hospital, Iga, JPN.

Cureus
|June 20, 2023
PubMed

Insights

Adhesive strapping (AS) for umbilical hernia (UH) is generally safe but can lead to serious complications like incarceration. Proper guidance is essential to prevent adverse events during UH treatment.

Area of Science:

  • Pediatric Surgery
  • Neonatal Care

Background:

  • Umbilical hernia (UH) is a common congenital condition in infants.
  • Most umbilical hernias resolve spontaneously, necessitating minimal active intervention.
  • Adhesive strapping (AS) is a minimally invasive technique for early umbilical hernia closure.

Observation:

  • A case report details a three-month-old infant experiencing incarcerated umbilical hernia during adhesive strapping therapy.
  • The infant also developed associated skin complications, including cellulitis and ulceration with perforation.
  • This highlights potential risks beyond expected outcomes of AS treatment.

Findings:

  • Adhesive strapping, while effective in observational studies, carries a risk of rare but severe complications.
  • Incarcerated umbilical hernia and significant skin issues like cellulitis and perforation are noteworthy adverse events.
  • The study underscores the importance of vigilant monitoring during AS therapy.

Implications:

  • Comprehensive patient and family education on AS management and prompt recognition of complications is crucial.
  • Global application of AS for umbilical hernias requires awareness of potential serious adverse events.
  • Further research into optimizing AS techniques and safety protocols is warranted to minimize risks.

Related Concept Videos